Search

Search Constraints

You searched for: Journal Channels

Search Results

1. "TRPV1 is a component of the atrial natriuretic signaling complex, and using orally delivered antagonists, presents a valid therapeutic target in the longitudinal reversal and treatment of cardiac hypertrophy and heart failure". Issue 1 (1st January 2019)